These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35073787)

  • 21. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
    Willén K; Sroka A; Takahashi RH; Gouras GK
    J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid Fibril-Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses.
    Wu J; Bie B; Foss JF; Naguib M
    Mol Neurobiol; 2020 May; 57(5):2290-2300. PubMed ID: 32008166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic Tau in Alzheimer's Disease.
    Ittner A; Ittner LM
    Neuron; 2018 Jul; 99(1):13-27. PubMed ID: 30001506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model.
    Li W; Yu J; Liu Y; Huang X; Abumaria N; Zhu Y; Huang X; Xiong W; Ren C; Liu XG; Chui D; Liu G
    Mol Brain; 2014 Sep; 7():65. PubMed ID: 25213836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
    Pereira C; Agostinho P; Moreira PI; Cardoso SM; Oliveira CR
    Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):383-403. PubMed ID: 16101556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.
    Rajmohan R; Reddy PH
    J Alzheimers Dis; 2017; 57(4):975-999. PubMed ID: 27567878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intersection of amyloid beta and tau at synapses in Alzheimer's disease.
    Spires-Jones TL; Hyman BT
    Neuron; 2014 May; 82(4):756-71. PubMed ID: 24853936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
    Jha SK; Jha NK; Kumar D; Sharma R; Shrivastava A; Ambasta RK; Kumar P
    J Alzheimers Dis; 2017; 57(4):1017-1039. PubMed ID: 27662312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.
    Izzo NJ; Yuede CM; LaBarbera KM; Limegrover CS; Rehak C; Yurko R; Waybright L; Look G; Rishton G; Safferstein H; Hamby ME; Williams C; Sadlek K; Edwards HM; Davis CS; Grundman M; Schneider LS; DeKosky ST; Chelsky D; Pike I; Henstridge C; Blennow K; Zetterberg H; LeVine H; Spires-Jones TL; Cirrito JR; Catalano SM
    Alzheimers Dement; 2021 Aug; 17(8):1365-1382. PubMed ID: 33559354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer's disease.
    Lin CH; Huang YJ; Lin CJ; Lane HY; Tsai GE
    Curr Pharm Des; 2014; 20(32):5169-79. PubMed ID: 24410566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of pathological tau in synaptic dysfunction in Alzheimer's diseases.
    Wu M; Zhang M; Yin X; Chen K; Hu Z; Zhou Q; Cao X; Chen Z; Liu D
    Transl Neurodegener; 2021 Nov; 10(1):45. PubMed ID: 34753506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.
    Leo D; Targa G; Espinoza S; Villers A; Gainetdinov RR; Ris L
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. POTENTIAL APPROACHES FOR REDUCING AMYLOID β PRODUCTION.
    Zheng C; Lan Y; Zhang J; Zhang L; Wu J; Guo S
    Acta Pol Pharm; 2016 Jul; 73(4):835-842. PubMed ID: 29648708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks.
    Palop JJ; Mucke L
    Nat Neurosci; 2010 Jul; 13(7):812-8. PubMed ID: 20581818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.
    Nava-Mesa MO; Jiménez-Díaz L; Yajeya J; Navarro-Lopez JD
    Front Cell Neurosci; 2014; 8():167. PubMed ID: 24987334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease.
    Bi D; Wen L; Wu Z; Shen Y
    Alzheimers Dement; 2020 Sep; 16(9):1312-1329. PubMed ID: 32543726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease.
    Gouras GK; Willén K; Faideau M
    Neurodegener Dis; 2014; 13(2-3):142-6. PubMed ID: 24080821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.